Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Technology Diagnostics & Research Information Technology Services

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc

Bullboard Posts

Post by kingposton Jun 24, 2016 2:25pm

126 Views

Post# 24996557

US generic news...

Mylan N.V.'s (MYL -5%) U.S. launch of its generic version of GlaxoSmithKline's (GSK -3.4%) prostate drug Avodart (dutasteride) is underway. According to IMS, the U.S. market is ~$300M.

Dutasteride is indicated for the treatment of men with symptomatic benign prostate hyperplasia (enlarged prostate).

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property